Répertoire des subventions financées

Filtrer par

562 ésultat(s) trouvé(s)

Relevance of stress granule dynamics to ALS pathogenesis in vivo

  • Type de programme

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS FR

  • Compétition

    Société canadienne de la SLA - Fondation Brain Canada - Bourses de découverte

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $300,000

Aperçu du projet

Amyotrophic lateral sclerosis (ALS) also known as Lou Gehrig’s Disease, is a neurodegenerative disease for which there is no effective treatment. The disease affects motor neurons, which are nerve cells that control the voluntary movement of muscles. These cells are under constant stress in ALS patients and eventually die, resulting…

Correlating quaternary structure of pathological protein aggregates with phenotypic presentation of ALS

  • Type de programme

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS FR

  • Compétition

    Société canadienne de la SLA - Fondation Brain Canada - Bourses de découverte

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $125,000

Aperçu du projet

Amyotrophic lateral sclerosis (ALS) is a disease of progressive weakness that leads to death within a few years of onset. The disease can start in one arm, leg, or face, but it inevitably spreads to all areas, killing cells as it spreads. What if, once the disease starts, we could…

Investigating mechanisms of altered lipid droplet dynamics in ALS

  • Type de programme

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS FR

  • Compétition

    Société canadienne de la SLA - Fondation Brain Canada - Bourses de découverte

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $125,000

Aperçu du projet

In Canada, the annual cost to care for individuals with neurodegenerative diseases is over $10.4 billion. There are no therapeutic interventions that sufficiently prevent or treat neurodegenerative diseases because the cause of neurodegeneration is complex and not well understood. Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease caused by…

Investigating inhibition of TDP-43 propagation as a therapeutic strategy for ALS

  • Type de programme

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS FR

  • Compétition

    Société canadienne de la SLA - Fondation Brain Canada - Bourses de découverte

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $125,000

Aperçu du projet

It is not known why ALS is a rapidly progressing disease. The discovery that the accumulation of TAR DNA-binding protein 43 kDa (TDP-43) is a pathological hallmark of sporadic ALS and a subset of frontotemporal lobar degeneration (FTLD) provides clues. TDP-43 is prone to incorrect folding and it has been…

Dynamic palmitoylation regulates TDP-43 nucleocytoplasmic transport in ALS

  • Type de programme

    Team grants

  • Domaine de recherche

    Neurodegeneration

  • Disease Area

    ALS FR

  • Compétition

    Société canadienne de la SLA - Fondation Brain Canada - Bourses de découverte

  • Province

    Québec

  • Date de Début

    2024

  • Montant total du financement

    $125,000

Aperçu du projet

Common features in amyotrophic lateral sclerosis (ALS) include misdirected proteins that build up over time and lead to large protein clumps that are toxic to the cell and lead to cell death. In ALS, special cells known as motor neurons are particularly affected. These neurons have very long extensions known…